Aperio Group’s NxStage Medical Inc. NXTM Stock Holding History

Aperio Group’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-19,159	Closed	-$549K	–	2337
2018 Q4	$549K	Buy	19,159 +3,031	+19%	+$86.1K	﹤0.01%	1625
2018 Q3	$450K	Buy	16,128 +1,604	+11%	+$45.1K	﹤0.01%	1820
2018 Q2	$405K	Buy	14,524 +677	+5%	+$18.2K	﹤0.01%	1850
2018 Q1	$344K	Buy	13,847 +2,899	+26%	+$70.5K	﹤0.01%	1885
2017 Q4	$265K	Sell	10,948 -175	-2%	-$4.61K	﹤0.01%	2015
2017 Q3	$307K	Buy	11,123 +2,990	+37%	+$79.7K	﹤0.01%	1909
2017 Q2	$204K	Sell	8,133 -1,412	-15%	-$35K	﹤0.01%	2094
2017 Q1	$256K	Buy	+9,545	New	+$264K	﹤0.01%	1903

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Aperio Group's NXTM Position: Q1 2019 in Review

Aperio Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 19,159 shares — an estimated $549K sold.

Aperio Group first reported a position in NXTM in Q1 2017 and held it in 8 quarters. The position peaked at $549K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Aperio Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Aperio Group sold 19,159 NxStage Medical Inc. shares in Q1 2019, an estimated $549K.
Aperio Group first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 8 quarters.
Aperio Group's NxStage Medical Inc. position peaked at $549K in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Aperio Group's 13F filing for Q1 2019, filed 13 May 2019.